{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["10(1)"],"submitter":["Reda S"],"pubmed_abstract":["Functional tests for lupus anticoagulants (LA) as part of a thrombophilia workup are commonly performed in patients under anticoagulant therapy that may interfere with assay results. There is no consensus on how these tests should be assessed in patients on direct oral anticoagulants (DOACs). In this retrospective cohort study, we analysed data from patients with a history of thrombosis in whom dilute Russell viper venom time (dRVVT), LA-sensitive aPTT, and solid phase assays for antiphospholipid antibodies (aPL) were performed (n = 3,147, thereof 588 on rivaroxaban, 144 on apixaban, 1,179 on other anticoagulant drugs). The dRVVT ratio was correlated with rivaroxaban (r = 0.30, P < 10<sup>-4</sup>) but not with apixaban plasma levels. The LA-sensitive aPTT/aPTT ratio showed no correlation "],"journal":["Scientific reports"],"pagination":["12221"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7376154"],"repository":["biostudies-literature"],"pubmed_title":["Functional lupus anticoagulant testing in a large retrospective cohort of thrombosis patients with direct oral anticoagulants."],"pmcid":["PMC7376154"],"pubmed_authors":["Ruhl H","Reda S","Oldenburg J","Brugelmann A","Muller J","Potzsch B"],"additional_accession":[]},"is_claimable":false,"name":"Functional lupus anticoagulant testing in a large retrospective cohort of thrombosis patients with direct oral anticoagulants.","description":"Functional tests for lupus anticoagulants (LA) as part of a thrombophilia workup are commonly performed in patients under anticoagulant therapy that may interfere with assay results. There is no consensus on how these tests should be assessed in patients on direct oral anticoagulants (DOACs). In this retrospective cohort study, we analysed data from patients with a history of thrombosis in whom dilute Russell viper venom time (dRVVT), LA-sensitive aPTT, and solid phase assays for antiphospholipid antibodies (aPL) were performed (n = 3,147, thereof 588 on rivaroxaban, 144 on apixaban, 1,179 on other anticoagulant drugs). The dRVVT ratio was correlated with rivaroxaban (r = 0.30, P < 10<sup>-4</sup>) but not with apixaban plasma levels. The LA-sensitive aPTT/aPTT ratio showed no correlation ","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Jul","modification":"2025-04-05T12:42:30.881Z","creation":"2025-04-05T12:42:30.881Z"},"accession":"S-EPMC7376154","cross_references":{"pubmed":["32699227"],"doi":["10.1038/s41598-020-69199-1"]}}